Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,250
Funds Holding Change
+374
Funds Holding Growth
+10%
Value
$1.36T
Holding in Top 10
1,118
Top 10 Change
-55
Top 10 Growth
-5%
Value Growth
+5%
New
528
Increased
1,822
Reduced
1,759
Closed
91
Capital Inflow
$45.1B
Capital Outflow
$40.2B
Net Capital Flow
+$4.88B
Capital Flow Change
+$3.63B
Calls
$17.3B
Puts
$17B
Net Calls
+$302M
Put/Call Ratio
0.98